ScholarIQanswers from OpenAlex
Intarcia Therapeutics (United States)
InstitutionResearch output, impact & collaborations
Intarcia Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Intarcia Therapeutics (United States)?
ScholarIQrecord summary
Intarcia Therapeutics (United States) is a research organisation in Boston, US. OpenAlex records 229 works and 55,615 citations for it. 276 researchers list it as their most recent affiliation.
How many works does Intarcia Therapeutics (United States) have?
ScholarIQindexed works
Intarcia Therapeutics (United States) has 229 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Intarcia Therapeutics (United States) have?
ScholarIQcitation count
Intarcia Therapeutics (United States) has 55,615 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Intarcia Therapeutics (United States)?
ScholarIQresearcher count
Intarcia Therapeutics (United States) has 276 researchers in the ScholarIQ index.
What is the average h-index at Intarcia Therapeutics (United States)?
ScholarIQavg h-index
Intarcia Therapeutics (United States) has an average h-index of 48 in OpenAlex.
What is the ROR of Intarcia Therapeutics (United States)?
ScholarIQror
The ROR for Intarcia Therapeutics (United States) is on the source record.
What is the OpenAlex record for Intarcia Therapeutics (United States)?
ScholarIQopenalex
The OpenAlex for Intarcia Therapeutics (United States) is on the source record.
Who are the most-cited researchers behind Intarcia Therapeutics (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Intarcia Therapeutics (United States)?
ScholarIQmost cited works
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky, Ann Marie Egloff, Aaron D. Tward, Aleksandar D. Kostic, Kristian Cibulskis, Andrey Sivachenko, Gregory V. Kryukov, Michael S. Lawrence, Carrie Sougnez, Aaron McKenna, Erica Shefler, Alex H. Ramos, Petar Stojanov, Scott L. Carter, Douglas Voet, Maria L. Cortés, Daniel Auclair, Michael F. Berger, Gordon Saksena, Candace Guiducci, Robert C. Onofrio, Melissa Parkin, Marjorie Romkes, Joel L. Weissfeld, Raja R. Seethala, Lin Wang, Claudia Rangel‐Escareño, Juan Carlos Fernández-López, Alfredo Hidalgo‐Miranda, Jorge Meléndez-Zajgla, Wendy Winckler, Kristin Ardlie, Stacey Gabriel, Matthew Meyerson, Eric S. Lander, Gad Getz, Todd R. Golub, Levi A. Garraway, Jennifer R. Grandis
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass, Hideo Watanabe, Craig H. Mermel, Soyoung Yu, Sven Perner, Roel G.W. Verhaak, So Young Kim, Leslie Wardwell, Pablo Tamayo, Irit Gat‐Viks, Alex H. Ramos, Michele Sue‐Ann Woo, Barbara A. Weir, Gad Getz, Rameen Beroukhim, Michael O'Kelly, Amit Dutt, Orit Rozenblatt–Rosen, Piotr Dziunycz, Justin Komisarof, Lucian R. Chirieac, Christopher J. Lafargue, Veit Scheble, Theresia Wilbertz, Changqing Ma, Shilpa Rao, Hiroshi Nakagawa, Douglas B. Stairs, Lin Lin, Thomas J. Giordano, Patrick Wagner, John D. Minna, Adi F. Gazdar, Chang‐Qi Zhu, Marcia S. Brose, Ivan Cecconello, Ulysses Ribeiro, Suely Kazue Nagahashi Marie, Olav Dahl, Ramesh A. Shivdasani, Ming‐Sound Tsao, Mark A. Rubin, Kwok‐Kin Wong, Aviv Regev, William C. Hahn, David G. Beer, Anil K. Rustgi, Matthew Meyerson
Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
Peter S. Hammerman, Martin L. Sos, Alex H. Ramos, Chunxiao Xu, Amit Dutt, Wenjun Zhou, Lear E. Brace, Brittany A. Woods, Wenchu Lin, Jianming Zhang, Xianming Deng, Sang Min Lim, Stefanie Heynck, Martin Peifer, Jeffrey R. Simard, Michael S. Lawrence, Robert C. Onofrio, Helga B. Salvesen, Danila Seidel, Thomas Zander, Johannes M. Heuckmann, Alex Soltermann, Holger Moch, Mirjam Koker, Frauke Leenders, Franziska Gabler, Silvia Querings, Sascha Ansén, Élisabeth Brambilla, Christian Brambilla, Philippe Lorimier, Odd Terje Brustugun, Åslaug Helland, Iver Petersen, Joachim H. Clement, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Erich Stoelben, Jürgen Wolf, David G. Beer, Ming‐Sound Tsao, Megan Hanna, Charlie Hatton, Michael J. Eck, Pasi A. Jänne, Bruce E. Johnson, Wendy Winckler, Heidi Greulich, Adam J. Bass, Jeonghee Cho, Daniel Rauh, Nathanael S. Gray, Kwok‐Kin Wong, Eric B. Haura, Roman K. Thomas, Matthew Meyerson
How much of the research on Intarcia Therapeutics (United States) is open access?
ScholarIQopen access share
100%OPEN ACCESS